HNI:NYSEHNI Corporation Analysis
Data as of 2026-05-21 - not real-time
$30.44
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
HNI’s stock is trading at $30.44, well below its 20‑day (34.05), 50‑day (35.14) and 200‑day (42.07) simple moving averages, signaling a bearish technical backdrop. The MACD histogram remains negative and the RSI sits at 35, hinting at oversold conditions but also confirming limited upside momentum. Valuation metrics are extreme: a trailing P/E of 112× contrasts sharply with a forward P/E of 6.3× and a discounted cash‑flow fair value of just $8.39, implying the market is pricing in a substantial premium. Dividend sustainability is doubtful given a 4.6% yield paired with a payout ratio exceeding 500%, and the company’s leverage is high (debt‑to‑equity ~97%).
Despite the technical weakness, the latest quarter showed a 125% year‑over‑year revenue surge to $1.35 billion and non‑GAAP EPS beat expectations, driven by cost controls and pricing actions in the Workplace Furnishings segment. However, operating margins remain thin (≈1.5%) and free cash flow is negative, while the balance sheet carries $1.73 billion of debt. The mixed earnings narrative, combined with elevated 30‑day volatility (≈48%) and a beta near 1, suggests that any upside will be contingent on sustaining growth and improving cash generation.
Despite the technical weakness, the latest quarter showed a 125% year‑over‑year revenue surge to $1.35 billion and non‑GAAP EPS beat expectations, driven by cost controls and pricing actions in the Workplace Furnishings segment. However, operating margins remain thin (≈1.5%) and free cash flow is negative, while the balance sheet carries $1.73 billion of debt. The mixed earnings narrative, combined with elevated 30‑day volatility (≈48%) and a beta near 1, suggests that any upside will be contingent on sustaining growth and improving cash generation.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bearish technical indicators (price below all SMAs, negative MACD)
- Extreme valuation gap versus DCF fair value
- Unsustainable dividend payout
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong quarterly revenue growth and EPS beat
- Improving forward earnings outlook (forward EPS 4.84)
- High leverage and thin operating margins
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Persistently high valuation multiples
- Debt burden and negative free cash flow
- Volatile earnings and sector cyclicality
Key Metrics & Analysis
Financial Health
Revenue Growth124.70%
Profit Margin0.04%
P/E Ratio112.7
ROE0.12%
ROA4.34%
Debt/Equity97.41
P/B Ratio1.2
Op. Cash Flow$91.9M
Free Cash Flow$-5450000
Technical Analysis
TrendBearish
RSI35.6
Support$28.93
Resistance$37.99
MA 20$34.05
MA 50$35.14
MA 200$42.07
MACDBearish
VolumeIncreasing
Fear & Greed Index90.29
Valuation
Fair Value$8.39
Target Price$69.00
Upside/Downside126.68%
GradeOvervalued
TypeGrowth
Dividend Yield4.60%
Risk Assessment
Beta1.00
Volatility48.12%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.